The Prevalence of Chronic Obstructive Pulmonary Disease among Danes Aged 45–84 Years: Population-based Study

REFERENCES

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronis Obstructive Pulmonary Disease, http://www.goldcopd.org.2004(updated 2005)
   Google Scholar
• Rennard S I, Vestbo J. COPD: The dangerous underestimate of 15% (comment). Lancet 2006; 367: 1216–1219
   PubMed Web of Science ®Google Scholar
• Burrows B, Knudson R J, Cline M G, Lebowitz M D. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1977; 115: 195–205
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935–939
   PubMed Web of Science ®Google Scholar
• Liu Y, Lee K, Perez-Padilla R, Hudson N L, Mannino D M. Outdoor and indoor air pollution and COPD –related diseases in high- and low-income countries. Int J Tuberc Lung Dis 2008; 12: 115–127
   PubMed Web of Science ®Google Scholar
• Jensen H H, Godtfredsen N S, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur RespirJ 2006; 28: 781–785
   PubMed Web of Science ®Google Scholar
• Juel K, Døssing M. Koli Danmark. Statens Institut for Folkesundhed. København 2003. COPD in Denmark, National Institute of Public Health, Copenhagen 2003
   Google Scholar
• Tinkelman D G, Price D B, Nordyke R J, Halbert R J. COPD screening efforts in primary care: what is the yield?. Prim Care RespirJ 2007; 16: 41–48
   PubMedGoogle Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo R O, Burgos F, Casaburi R, Coates A, van der Grinten C P, Gustafsson P, Hankinson J, Jensen R, Johnson D C, MacIntyre N, McKay R, Miler M R, Navajas D, Pedersen O F, Wanger J. Interpretative strategies for lung function tests. Eur RespirJ 2005; 26: 948–968
   PubMed Web of Science ®Google Scholar
• Lange P, Groth S, Nyboe J, Appleyard M, Mortensen J, Jensen G, Schnoor P. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989; 226: 25–32
   PubMed Web of Science ®Google Scholar
• Quanjer P H, Tammeling G J, Cotes J E, Pedersen O F, Peslin R, Yernault J C. Official statement on lung volumes and forced ventilatory flows. Eur RespirJ 1993; 6(Suppl. 16)5–40
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry:1994 update. Am J Respir Crit Care Med 1995; 152: 1107–1132
   PubMed Web of Science ®Google Scholar
• Danish Respiratory Society. Spirometry—a recommendation (in Danish). Danish Respiratory Society, Copenhagen 1986
   Google Scholar
• Halbert R J, Natoli J L, Gano A, Badamgarav E, Buist A S, Mannino D M. Global burden of COPD; systematic review and meta-analysis. Eur RespiJ 2006; 28: 523–532
   PubMed Web of Science ®Google Scholar
• Hansen J E, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction. Chest 2007; 131: 349–355
   PubMed Web of Science ®Google Scholar
• Snow W M, Connett J E, Sharma S, Murray R P. Predictors of attendance and dropout at the Lung Health Study 11 years follow-up. Contemp Clin Trials 2007; 28: 25–32
   PubMed Web of Science ®Google Scholar
• Pedersen S T, Christensen H R, Døssing M. Behandling af nikotinafhængighed. (in Danish) Ugeskr Læger 2002; 164: 1480–1484
   PubMedGoogle Scholar
• Schroeder S A. What to do with a patient who smokes. JAMA 2005; 294: 482–487
   PubMed Web of Science ®Google Scholar
• Ferguson G T, Enright P L, Buist A S, Higgins M W. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care 2000; 45: 513–530
   PubMedGoogle Scholar
• Dorinsky P M, Reisner C, Ferguson G T, Menjoge S S, Serby C W, Witek T J. The Combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. Chest 1999; 115: 966–971
   PubMed Web of Science ®Google Scholar
• Buist A S, McBurnie M A, Vollmer W M, Gillespie S, Burney P, Mannino D M, Menezes A MB, Sullivan S D, Lee T A, Weiss K B, Jensen R L, Marks G B, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–750
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson A C, Ronmark E, Lundgren R, Larsson L G, Lundback B. Prevalence of obstructive pulmonary disease according to BTS, ERS, Gold and ATS criteria in relation to doctors diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005; 72(5)47–49
   Google Scholar
• Kim D S, Kim Y S, Jung K-S, Chang J H, Lim C-M, Lee J H, Uh S-T, Shim J J, Lew W J. Prevalence of Chronic Obstructive Pulmonary Disease in Korea. Am J Respir Crit Care Med 2005; 172: 842–847
   PubMed Web of Science ®Google Scholar
• Shahab L, Jarvis M J, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61: 1043–1047
   PubMed Web of Science ®Google Scholar
• Løkke A, Fabricius P G, Vestbo J, Marott J L, Lange P. Forekomst af kronisk obstruktiv lungesygdom i København. (in Danish). Ugeskr Læger 2007; 169: 3956–3960
   PubMedGoogle Scholar
• Renwick D S, Connolly M J. Prevalence of treatment of chronic airways obstruction in adults over the age of 45. Thorax 1996; 61: 164–168
   Google Scholar
• Schayck C P, van Loozen J MC, Wagena E, Akkermanns R P, Wesseling G J. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. Br MedJ 2002; 324: 1370
   PubMed Web of Science ®Google Scholar